Surprisingly, we found that BAFF treatment promotes the cell death of primary BCR-ABL+ BAFFR+ pre-B-lymphoblasts in adult B-ALL. This evidence concerns the gene ABL1 and precursor B-cell acute lymphoblastic leukemia.